Table 2 Concordance between GIS and shallowHRDv2 test on 109 tumor samples from Institut Curie routine laboratory.

From: Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial

 

ShallowHRDv2

positive

Negative

NC

GIS

Positive

36

3

0

Negative

5

50

2

NC

1

8

4

  1. NC non-contributive.
Back to article page